Minnesota FOIA #N009615001

ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications

This purchase order from Twin Cities to Olive View UCLA-Research, awarded on March 8, 2023, involves a single transaction for $87,000 to support the ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications. The vendor, Olive View UCLA-Research, located in Sylmar, California, is awarded for conducting a clinical trial related to COVID-19. The contract appears to be a one-time procurement for research services, with no indication of a multi-year or blanket arrangement. The award is categorized under research/contract services. The awardee, Olive View UCLA-Research, is a research entity affiliated with UCLA, and the buyer, Twin Cities, is a government or institutional entity. The award involves a NAICS code relevant to research and development activities. The procurement contacts and additional location details are not specified in the source data.

Description

ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications